NCT07280221Enrolling by invitation
WEgovy Real World Assessment of Weight Loss in Korea
WEgovy Real World Assessment of Weight Loss in Korea (WE-WALK): a Multi-centre, Prospective, Single-arm, Nonintervention Study to Investigate the Effectiveness and Safety of Once-weekly Semaglutide 2.4 mg for People Living With Obesity in Routine Clinical Practice in Korea
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
This study is to investigate the effectiveness and safety of Wegovy (semaglutide) in Korean patients living with obesity in routine clinical practice. The purpose of this study is to investigate the change in body weight and other clinical characteristics related to body weight in patients living with obesity. Participants will be treated with Wegovy (semaglutide) as prescribed by their doctor, in accordance with normal clinical practice. The study will last for about 52 weeks.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- 10 Nov 2025
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Obesity
- NCT number
- NCT07280221
What you commit to
- Study type: Observational
- Planned participants: 500
- From 10 Nov 2025 to the primary completion date, 31 Oct 2027
- 18 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in clinical studies including treatment with Wegovy (semaglutide). Participation is defined as providing informed consent in a previous study.
Other
- Female patient who is pregnant, breast-feeding, or intends to become pregnant and is of childbearing potential not using adequate contraceptive methods (adequate contraceptive measures as required by local regulation or practice).
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation.
Who the study is looking for
- Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- The decision to initiate treatment with commercially available Wegovy (semaglutide) has been made by the patient and the treating physician before and independently from the decision to include the patient in this study.
- Initiating treatment with Wegovy (semaglutide) for the first time and according to locally approved label.
- Male or female, aged ≥ 19 years at the time of signing the informed consent.
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (18)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dong-A University Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Inje University Haeundae Paik Hospital Coordinator of this site? Confirm its status | Busan | South Korea | Unknown status |
| Keimyung University Dongsan Hospital Coordinator of this site? Confirm its status | Daegu | South Korea | Unknown status |
| Konyang University Hospital Coordinator of this site? Confirm its status | Daejeon | South Korea | Unknown status |
| Daejeon Endo Internal Medicine Clinic Coordinator of this site? Confirm its status | Daejeon | South Korea | Unknown status |
| National Health Insurance Corporation Ilsan Hospital Coordinator of this site? Confirm its status | Goyang-si | South Korea | Unknown status |
| Chung-Ang University Gwangmyeong Hospital Coordinator of this site? Confirm its status | Gwangmyeong-si, Gyeonggi-do | South Korea | Unknown status |
| Seoul National University Bundang Hospital Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Unknown status |
| CHA Bundang Medical Center Coordinator of this site? Confirm its status | Seongnam-si, Gyeonggi-do | South Korea | Unknown status |
| Seoul Happiness Clinic of internal medicine Coordinator of this site? Confirm its status | Seongnam-si, Gyeonggi-do | South Korea | Unknown status |
| Chung ang University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Ewha Womans University Seoul Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Korea University Guro Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Ajou University Hospital Coordinator of this site? Confirm its status | Suwon | South Korea | Unknown status |
| The Catholic University of Korea Uijeongbu St. Mary's Hospital Coordinator of this site? Confirm its status | Uijeongbu-si | South Korea | Unknown status |
| Uijeongbu Eulji university Hospital Coordinator of this site? Confirm its status | Uijeongbu-si, Gyeonggi-do | South Korea | Unknown status |
| Pusan National University Yangsan Hospital Coordinator of this site? Confirm its status | Yangsan | South Korea | Unknown status |
| Yongin Severance Hospital Coordinator of this site? Confirm its status | Yongin-si | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.